Aldicarb poisoning: A case report with prolonged cholinesterase inhibition and improvement after pralidoxime therapy

J. L. Burgess, J. N. Bernstein, K. Hurlbut

Research output: Contribution to journalArticle

31 Scopus citations

Abstract

Aldicarb is the most potent of the commercially available carbamate pesticides and is an unusual source of acute human poisonings. We present the case of a 43-year-old man exposed to aldicarb who developed severe cholinergic symptoms and progressive weakness requiring intubation for 5 days. Both his red blood cell cholinesterase and plasma pseudocholinesterase levels were depressed for a minimum of 44 hours. He demonstrated neuromuscular improvement concurrent with pralidoxime administration. The pertinent medical literature on aldicarb poisoning is reviewed.

Original languageEnglish (US)
Pages (from-to)221-224
Number of pages4
JournalArchives of internal medicine
Volume154
Issue number2
DOIs
StatePublished - Jan 31 1994

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Aldicarb poisoning: A case report with prolonged cholinesterase inhibition and improvement after pralidoxime therapy'. Together they form a unique fingerprint.

  • Cite this